APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma and Health Care

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

Selected research

Market Analysis & Forecast

Global Pharma and Health Care Market Analysis and Forecast 2026-2032

30 December 2025209 pages

Choose your research edition.

Industry ResearchPharma and Health Care Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma and Health Care Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pharma and Health Care Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma and Health Care Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma and Health Care Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.

Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.

Report Includes

This report presents an overview of global market for Pharma and Health Care, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharma and Health Care, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharma and Health Care, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharma and Health Care revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharma and Health Care market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharma and Health Care revenue, projected growth trends, production technology, application and end-user industry.

Pharma and Health Care Segment by Company

Johnson & Johnson

Novartis

Roche

AbbVie

Merck & Co.

Bristol Myers Squibb

GlaxoSmithKline

Pfizer

Sanofi

Takeda

AstraZeneca

Bayer

Eli Lilly & Co.

Gilead Sciences

Amgen

Novo Nordisk

Teva

Boehringer Ingelheim

Biogen

Astellas

Pharma and Health Care Segment by Format

Bottle

Blister

Others

Pharma and Health Care Segment by Prescription

OTC Drugs

Prescription Drugs

Pharma and Health Care Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma and Health Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma and Health Care and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma and Health Care.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharma and Health Care in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharma and Health Care company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma and Health Care revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bottle Major Player Table 3. Blister Major Player Table 4. Others Major Player Table 5. Global Pharma and Health Care Market Size Growth Rate by Prescription (US$ Million), 2021 VS 2025 VS 2032 Table 6. OTC Drugs Major Player Table 7. Prescription Drugs Major Player Table 8. Pharma and Health Care Industry Trends Table 9. Pharma and Health Care Industry Drivers Table 10. Pharma and Health Care Industry Opportunities and Challenges Table 11. Pharma and Health Care Industry Restraints Table 12. Global Pharma and Health Care Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Pharma and Health Care Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Pharma and Health Care Market Share by Region (2021-2026) Table 15. Global Pharma and Health Care Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Pharma and Health Care Market Share by Region (2027-2032) Table 17. Global Pharma and Health Care Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Pharma and Health Care Revenue Market Share by Players (2021-2026) Table 19. Global Pharma and Health Care Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharma and Health Care Key Players Headquarters & Area Served Table 21. Global Pharma and Health Care Players, Product Type & Application Table 22. Global Pharma and Health Care Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharma and Health Care by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Pharma and Health Care Revenue by Format 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharma and Health Care Revenue by Format (2021-2026) & (US$ Million) Table 27. Global Pharma and Health Care Revenue by Format (2027-2032) & (US$ Million) Table 28. Global Pharma and Health Care Revenue Market Share by Format (2021-2026) Table 29. Global Pharma and Health Care Revenue Market Share by Format (2027-2032) Table 30. Global Pharma and Health Care Revenue by Prescription 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharma and Health Care Revenue by Prescription (2021-2026) & (US$ Million) Table 32. Global Pharma and Health Care Revenue by Prescription (2027-2032) & (US$ Million) Table 33. Global Pharma and Health Care Revenue Market Share by Prescription (2021-2026) Table 34. Global Pharma and Health Care Revenue Market Share by Prescription (2027-2032) Table 35. Johnson & Johnson Company Information Table 36. Johnson & Johnson Business Overview Table 37. Johnson & Johnson Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Johnson & Johnson Pharma and Health Care Product Portfolio Table 39. Johnson & Johnson Recent Development Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis Pharma and Health Care Product Portfolio Table 44. Novartis Recent Development Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Roche Pharma and Health Care Product Portfolio Table 49. Roche Recent Development Table 50. AbbVie Company Information Table 51. AbbVie Business Overview Table 52. AbbVie Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AbbVie Pharma and Health Care Product Portfolio Table 54. AbbVie Recent Development Table 55. Merck & Co. Company Information Table 56. Merck & Co. Business Overview Table 57. Merck & Co. Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Merck & Co. Pharma and Health Care Product Portfolio Table 59. Merck & Co. Recent Development Table 60. Bristol Myers Squibb Company Information Table 61. Bristol Myers Squibb Business Overview Table 62. Bristol Myers Squibb Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bristol Myers Squibb Pharma and Health Care Product Portfolio Table 64. Bristol Myers Squibb Recent Development Table 65. GlaxoSmithKline Company Information Table 66. GlaxoSmithKline Business Overview Table 67. GlaxoSmithKline Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GlaxoSmithKline Pharma and Health Care Product Portfolio Table 69. GlaxoSmithKline Recent Development Table 70. Pfizer Company Information Table 71. Pfizer Business Overview Table 72. Pfizer Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Pfizer Pharma and Health Care Product Portfolio Table 74. Pfizer Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sanofi Pharma and Health Care Product Portfolio Table 79. Sanofi Recent Development Table 80. Takeda Company Information Table 81. Takeda Business Overview Table 82. Takeda Pharma and Health Care Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Takeda Pharma and Health Care Product Portfolio Table 84. Takeda Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. AstraZeneca Pharma and Health Care Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Bayer Pharma and Health Care Product Portfolio Table 94. Bayer Recent Development Table 95. Eli Lilly & Co. Company Information Table 96. Eli Lilly & Co. Business Overview Table 97. Eli Lilly & Co. Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Eli Lilly & Co. Pharma and Health Care Product Portfolio Table 99. Eli Lilly & Co. Recent Development Table 100. Gilead Sciences Company Information Table 101. Gilead Sciences Business Overview Table 102. Gilead Sciences Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Gilead Sciences Pharma and Health Care Product Portfolio Table 104. Gilead Sciences Recent Development Table 105. Amgen Company Information Table 106. Amgen Business Overview Table 107. Amgen Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Amgen Pharma and Health Care Product Portfolio Table 109. Amgen Recent Development Table 110. Novo Nordisk Company Information Table 111. Novo Nordisk Business Overview Table 112. Novo Nordisk Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Novo Nordisk Pharma and Health Care Product Portfolio Table 114. Novo Nordisk Recent Development Table 115. Teva Company Information Table 116. Teva Business Overview Table 117. Teva Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Teva Pharma and Health Care Product Portfolio Table 119. Teva Recent Development Table 120. Boehringer Ingelheim Company Information Table 121. Boehringer Ingelheim Business Overview Table 122. Boehringer Ingelheim Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Boehringer Ingelheim Pharma and Health Care Product Portfolio Table 124. Boehringer Ingelheim Recent Development Table 125. Biogen Company Information Table 126. Biogen Business Overview Table 127. Biogen Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Biogen Pharma and Health Care Product Portfolio Table 129. Biogen Recent Development Table 130. Astellas Company Information Table 131. Astellas Business Overview Table 132. Astellas Pharma and Health Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Astellas Pharma and Health Care Product Portfolio Table 134. Astellas Recent Development Table 135. North America Pharma and Health Care Revenue by Format (2021-2026) & (US$ Million) Table 136. North America Pharma and Health Care Revenue by Format (2027-2032) & (US$ Million) Table 137. North America Pharma and Health Care Revenue by Prescription (2021-2026) & (US$ Million) Table 138. North America Pharma and Health Care Revenue by Prescription (2027-2032) & (US$ Million) Table 139. North America Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Pharma and Health Care Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Pharma and Health Care Revenue by Country (US$ Million) & (2027-2032) Table 142. Europe Pharma and Health Care Revenue by Format (2021-2026) & (US$ Million) Table 143. Europe Pharma and Health Care Revenue by Format (2027-2032) & (US$ Million) Table 144. Europe Pharma and Health Care Revenue by Prescription (2021-2026) & (US$ Million) Table 145. Europe Pharma and Health Care Revenue by Prescription (2027-2032) & (US$ Million) Table 146. Europe Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Pharma and Health Care Revenue by Country (2021-2026) & (US$ Million) Table 148. Europe Pharma and Health Care Revenue by Country (US$ Million) & (2027-2032) Table 149. China Pharma and Health Care Revenue by Format (2021-2026) & (US$ Million) Table 150. China Pharma and Health Care Revenue by Format (2027-2032) & (US$ Million) Table 151. China Pharma and Health Care Revenue by Prescription (2021-2026) & (US$ Million) Table 152. China Pharma and Health Care Revenue by Prescription (2027-2032) & (US$ Million) Table 153. Asia Pharma and Health Care Revenue by Format (2021-2026) & (US$ Million) Table 154. Asia Pharma and Health Care Revenue by Format (2027-2032) & (US$ Million) Table 155. Asia Pharma and Health Care Revenue by Prescription (2021-2026) & (US$ Million) Table 156. Asia Pharma and Health Care Revenue by Prescription (2027-2032) & (US$ Million) Table 157. Asia Pharma and Health Care Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Pharma and Health Care Revenue by Region (US$ Million) & (2021-2026) Table 159. Asia Pharma and Health Care Revenue by Region (US$ Million) & (2027-2032) Table 160. SAMEA Pharma and Health Care Revenue by Format (2021-2026) & (US$ Million) Table 161. SAMEA Pharma and Health Care Revenue by Format (2027-2032) & (US$ Million) Table 162. SAMEA Pharma and Health Care Revenue by Prescription (2021-2026) & (US$ Million) Table 163. SAMEA Pharma and Health Care Revenue by Prescription (2027-2032) & (US$ Million) Table 164. SAMEA Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Pharma and Health Care Revenue by Country (2021-2026) & (US$ Million) Table 166. SAMEA Pharma and Health Care Revenue by Country (US$ Million) & (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Pharma and Health Care Image Figure 2. Global Pharma and Health Care Market Size Growth Rate by Format (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma and Health Care Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bottle Image Figure 5. Blister Image Figure 6. Others Image Figure 7. Global Pharma and Health Care Market Size Growth Rate by Prescription (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pharma and Health Care Market Size Share 2021 VS 2025 VS 2032 Figure 9. OTC Drugs Image Figure 10. Prescription Drugs Image Figure 11. Global Pharma and Health Care Market Size (US$ Million) & (2021-2032) Figure 12. Global Pharma and Health Care Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharma and Health Care Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Pharma and Health Care Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Pharma and Health Care Revenue by Format (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharma and Health Care Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Pharma and Health Care Revenue Market Share by Format (2021-2032) Figure 19. Global Pharma and Health Care Revenue by Prescription (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharma and Health Care Revenue Market Share by Prescription (2021 VS 2025 VS 2032) Figure 21. Global Pharma and Health Care Revenue Market Share by Prescription (2021-2032) Figure 22. North America Pharma and Health Care Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pharma and Health Care Revenue Share by Type (2021-2032) Figure 24. North America Pharma and Health Care Revenue Share by Application (2021-2032) Figure 25. North America Pharma and Health Care Revenue Share by Country (2021-2032) Figure 26. United States Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Pharma and Health Care Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Pharma and Health Care Revenue Share by Type (2021-2032) Figure 31. Europe Pharma and Health Care Revenue Share by Application (2021-2032) Figure 32. Europe Pharma and Health Care Revenue Share by Country (2021-2032) Figure 33. Germany Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Pharma and Health Care Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Pharma and Health Care Revenue Share by Type (2021-2032) Figure 43. China Pharma and Health Care Revenue Share by Application (2021-2032) Figure 44. Asia Pharma and Health Care Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Pharma and Health Care Revenue Share by Type (2021-2032) Figure 46. Asia Pharma and Health Care Revenue Share by Application (2021-2032) Figure 47. Asia Pharma and Health Care Revenue Share by Region (2021-2032) Figure 48. Japan Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Pharma and Health Care Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Pharma and Health Care Revenue Share by Type (2021-2032) Figure 56. SAMEA Pharma and Health Care Revenue Share by Application (2021-2032) Figure 57. SAMEA Pharma and Health Care Revenue Share by Country (2021-2032) Figure 58. Brazil Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Pharma and Health Care Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Bottle
  • Blister
  • Others
Applications
  • OTC Drugs
  • Prescription Drugs
Companies covered
  • Johnson & Johnson
  • Novartis
  • Roche
  • AbbVie
  • Merck & Co.
  • Bristol Myers Squibb
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Takeda
  • AstraZeneca
  • Bayer
  • Eli Lilly & Co.
  • Gilead Sciences
  • Amgen
  • Novo Nordisk
  • Teva
  • Boehringer Ingelheim
  • Biogen
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharma and Health Care Market by Format
  3. 1.2.1 Global Pharma and Health Care Market Size by Format, 2021 VS 2025 VS 2032
  4. 1.2.2 Bottle
  5. 1.2.3 Blister
  6. 1.2.4 Others
  7. 1.3 Pharma and Health Care Market by Prescription
  8. 1.3.1 Global Pharma and Health Care Market Size by Prescription, 2021 VS 2025 VS 2032
  9. 1.3.2 OTC Drugs
  10. 1.3.3 Prescription Drugs
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pharma and Health Care Market Dynamics
  1. 2.1 Pharma and Health Care Industry Trends
  2. 2.2 Pharma and Health Care Industry Drivers
  3. 2.3 Pharma and Health Care Industry Opportunities and Challenges
  4. 2.4 Pharma and Health Care Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharma and Health Care Market Perspective (2021-2032)
  2. 3.2 Global Pharma and Health Care Growth Trends by Region
  3. 3.2.1 Global Pharma and Health Care Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharma and Health Care Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharma and Health Care Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharma and Health Care Revenue by Players
  2. 4.1.1 Global Pharma and Health Care Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharma and Health Care Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharma and Health Care Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharma and Health Care Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharma and Health Care Key Players Headquarters & Area Served
  7. 4.4 Global Pharma and Health Care Players, Product Type & Application
  8. 4.5 Global Pharma and Health Care Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharma and Health Care Market CR5 and HHI
  11. 4.6.3 2025 Pharma and Health Care Tier 1, Tier 2, and Tier 3
5 Pharma and Health Care Market Size by Type
  1. 5.1 Global Pharma and Health Care Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharma and Health Care Revenue by Type (2021-2032)
  3. 5.3 Global Pharma and Health Care Revenue Market Share by Type (2021-2032)
6 Pharma and Health Care Market Size by Application
  1. 6.1 Global Pharma and Health Care Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharma and Health Care Revenue by Application (2021-2032)
  3. 6.3 Global Pharma and Health Care Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson Pharma and Health Care Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson Pharma and Health Care Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Pharma and Health Care Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Pharma and Health Care Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Pharma and Health Care Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Pharma and Health Care Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 AbbVie
  20. 7.4.1 AbbVie Company Information
  21. 7.4.2 AbbVie Business Overview
  22. 7.4.3 AbbVie Pharma and Health Care Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AbbVie Pharma and Health Care Product Portfolio
  24. 7.4.5 AbbVie Recent Developments
  25. 7.5 Merck & Co.
  26. 7.5.1 Merck & Co. Company Information
  27. 7.5.2 Merck & Co. Business Overview
  28. 7.5.3 Merck & Co. Pharma and Health Care Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck & Co. Pharma and Health Care Product Portfolio
  30. 7.5.5 Merck & Co. Recent Developments
  31. 7.6 Bristol Myers Squibb
  32. 7.6.1 Bristol Myers Squibb Company Information
  33. 7.6.2 Bristol Myers Squibb Business Overview
  34. 7.6.3 Bristol Myers Squibb Pharma and Health Care Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bristol Myers Squibb Pharma and Health Care Product Portfolio
  36. 7.6.5 Bristol Myers Squibb Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Pharma and Health Care Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Pharma and Health Care Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Pharma and Health Care Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Pharma and Health Care Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Pharma and Health Care Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Pharma and Health Care Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Takeda
  56. 7.10.1 Takeda Company Information
  57. 7.10.2 Takeda Business Overview
  58. 7.10.3 Takeda Pharma and Health Care Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Takeda Pharma and Health Care Product Portfolio
  60. 7.10.5 Takeda Recent Developments
  61. 7.11 AstraZeneca
  62. 7.11.1 AstraZeneca Company Information
  63. 7.11.2 AstraZeneca Business Overview
  64. 7.11.3 AstraZeneca Pharma and Health Care Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AstraZeneca Pharma and Health Care Product Portfolio
  66. 7.11.5 AstraZeneca Recent Developments
  67. 7.12 Bayer
  68. 7.12.1 Bayer Company Information
  69. 7.12.2 Bayer Business Overview
  70. 7.12.3 Bayer Pharma and Health Care Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Pharma and Health Care Product Portfolio
  72. 7.12.5 Bayer Recent Developments
  73. 7.13 Eli Lilly & Co.
  74. 7.13.1 Eli Lilly & Co. Company Information
  75. 7.13.2 Eli Lilly & Co. Business Overview
  76. 7.13.3 Eli Lilly & Co. Pharma and Health Care Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Eli Lilly & Co. Pharma and Health Care Product Portfolio
  78. 7.13.5 Eli Lilly & Co. Recent Developments
  79. 7.14 Gilead Sciences
  80. 7.14.1 Gilead Sciences Company Information
  81. 7.14.2 Gilead Sciences Business Overview
  82. 7.14.3 Gilead Sciences Pharma and Health Care Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Gilead Sciences Pharma and Health Care Product Portfolio
  84. 7.14.5 Gilead Sciences Recent Developments
  85. 7.15 Amgen
  86. 7.15.1 Amgen Company Information
  87. 7.15.2 Amgen Business Overview
  88. 7.15.3 Amgen Pharma and Health Care Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Amgen Pharma and Health Care Product Portfolio
  90. 7.15.5 Amgen Recent Developments
  91. 7.16 Novo Nordisk
  92. 7.16.1 Novo Nordisk Company Information
  93. 7.16.2 Novo Nordisk Business Overview
  94. 7.16.3 Novo Nordisk Pharma and Health Care Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Novo Nordisk Pharma and Health Care Product Portfolio
  96. 7.16.5 Novo Nordisk Recent Developments
  97. 7.17 Teva
  98. 7.17.1 Teva Company Information
  99. 7.17.2 Teva Business Overview
  100. 7.17.3 Teva Pharma and Health Care Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Teva Pharma and Health Care Product Portfolio
  102. 7.17.5 Teva Recent Developments
  103. 7.18 Boehringer Ingelheim
  104. 7.18.1 Boehringer Ingelheim Company Information
  105. 7.18.2 Boehringer Ingelheim Business Overview
  106. 7.18.3 Boehringer Ingelheim Pharma and Health Care Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Boehringer Ingelheim Pharma and Health Care Product Portfolio
  108. 7.18.5 Boehringer Ingelheim Recent Developments
  109. 7.19 Biogen
  110. 7.19.1 Biogen Company Information
  111. 7.19.2 Biogen Business Overview
  112. 7.19.3 Biogen Pharma and Health Care Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Biogen Pharma and Health Care Product Portfolio
  114. 7.19.5 Biogen Recent Developments
  115. 7.20 Astellas
  116. 7.20.1 Astellas Company Information
  117. 7.20.2 Astellas Business Overview
  118. 7.20.3 Astellas Pharma and Health Care Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Astellas Pharma and Health Care Product Portfolio
  120. 7.20.5 Astellas Recent Developments
8 North America
  1. 8.1 North America Pharma and Health Care Revenue (2021-2032)
  2. 8.2 North America Pharma and Health Care Revenue by Format (2021-2032)
  3. 8.2.1 North America Pharma and Health Care Revenue by Format (2021-2026)
  4. 8.2.2 North America Pharma and Health Care Revenue by Format (2027-2032)
  5. 8.3 North America Pharma and Health Care Revenue Share by Format (2021-2032)
  6. 8.4 North America Pharma and Health Care Revenue by Prescription (2021-2032)
  7. 8.4.1 North America Pharma and Health Care Revenue by Prescription (2021-2026)
  8. 8.4.2 North America Pharma and Health Care Revenue by Prescription (2027-2032)
  9. 8.5 North America Pharma and Health Care Revenue Share by Prescription (2021-2032)
  10. 8.6 North America Pharma and Health Care Revenue by Country
  11. 8.6.1 North America Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharma and Health Care Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharma and Health Care Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharma and Health Care Revenue (2021-2032)
  2. 9.2 Europe Pharma and Health Care Revenue by Format (2021-2032)
  3. 9.2.1 Europe Pharma and Health Care Revenue by Format (2021-2026)
  4. 9.2.2 Europe Pharma and Health Care Revenue by Format (2027-2032)
  5. 9.3 Europe Pharma and Health Care Revenue Share by Format (2021-2032)
  6. 9.4 Europe Pharma and Health Care Revenue by Prescription (2021-2032)
  7. 9.4.1 Europe Pharma and Health Care Revenue by Prescription (2021-2026)
  8. 9.4.2 Europe Pharma and Health Care Revenue by Prescription (2027-2032)
  9. 9.5 Europe Pharma and Health Care Revenue Share by Prescription (2021-2032)
  10. 9.6 Europe Pharma and Health Care Revenue by Country
  11. 9.6.1 Europe Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharma and Health Care Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharma and Health Care Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharma and Health Care Revenue (2021-2032)
  2. 10.2 China Pharma and Health Care Revenue by Format (2021-2032)
  3. 10.2.1 China Pharma and Health Care Revenue by Format (2021-2026)
  4. 10.2.2 China Pharma and Health Care Revenue by Format (2027-2032)
  5. 10.3 China Pharma and Health Care Revenue Share by Format (2021-2032)
  6. 10.4 China Pharma and Health Care Revenue by Prescription (2021-2032)
  7. 10.4.1 China Pharma and Health Care Revenue by Prescription (2021-2026)
  8. 10.4.2 China Pharma and Health Care Revenue by Prescription (2027-2032)
  9. 10.5 China Pharma and Health Care Revenue Share by Prescription (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharma and Health Care Revenue (2021-2032)
  2. 11.2 Asia Pharma and Health Care Revenue by Format (2021-2032)
  3. 11.2.1 Asia Pharma and Health Care Revenue by Format (2021-2026)
  4. 11.2.2 Asia Pharma and Health Care Revenue by Format (2027-2032)
  5. 11.3 Asia Pharma and Health Care Revenue Share by Format (2021-2032)
  6. 11.4 Asia Pharma and Health Care Revenue by Prescription (2021-2032)
  7. 11.4.1 Asia Pharma and Health Care Revenue by Prescription (2021-2026)
  8. 11.4.2 Asia Pharma and Health Care Revenue by Prescription (2027-2032)
  9. 11.5 Asia Pharma and Health Care Revenue Share by Prescription (2021-2032)
  10. 11.6 Asia Pharma and Health Care Revenue by Country
  11. 11.6.1 Asia Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharma and Health Care Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharma and Health Care Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharma and Health Care Revenue (2021-2032)
  2. 12.2 SAMEA Pharma and Health Care Revenue by Format (2021-2032)
  3. 12.2.1 SAMEA Pharma and Health Care Revenue by Format (2021-2026)
  4. 12.2.2 SAMEA Pharma and Health Care Revenue by Format (2027-2032)
  5. 12.3 SAMEA Pharma and Health Care Revenue Share by Format (2021-2032)
  6. 12.4 SAMEA Pharma and Health Care Revenue by Prescription (2021-2032)
  7. 12.4.1 SAMEA Pharma and Health Care Revenue by Prescription (2021-2026)
  8. 12.4.2 SAMEA Pharma and Health Care Revenue by Prescription (2027-2032)
  9. 12.5 SAMEA Pharma and Health Care Revenue Share by Prescription (2021-2032)
  10. 12.6 SAMEA Pharma and Health Care Revenue by Country
  11. 12.6.1 SAMEA Pharma and Health Care Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharma and Health Care Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharma and Health Care Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst